Loading...
News 2017-08-24T18:49:01+00:00

Aperiomics Names Wynemah Fuller Operations Director

OriginalArticle: http://dc.citybizlist.com/article/455893/aperiomics-names-wynemah-fuller-operations-director Ashburn, VA , December 7, 2017 -- Aperiomics, a biotechnology company that harnesses the power of deep next-generation sequencing to identify all known pathogens (bacteria, virus, fungi or parasite) in a single test, today announced that Wynemah Fuller has joined the company as director of operations. Fuller brings

By | December 7th, 2017|

Company develops single test to identify infectious diseases

Original article: http://www.virginiabusiness.com/news/article/company-develops-single-test-to-identify-infectious-diseases Ashburn-based Aperiomics, a company that allows doctors to identify infectious diseases through a single test, says it has now received a total of $6 million from the National Science Foundation, as well as a $100,000 grant from Virginia’s Center for Innovative Technology. There’s an urgent need for Aperiomics’

By | December 1st, 2017|

Pathogen Detection Leader Aperiomics Expands International Reach With Milenia Labs

Ashburn, VA, November 8, 2017 -- Aperiomics, a biotechnology company that harnesses the power of deep next-generation sequencing to identify all known pathogens (bacteria, virus, fungi or parasite) in a single test, today announced that it is partnering with Milenia Labs to further expand its international outreach. Milenia, based in

By | November 8th, 2017|

Biotech Aperiomics Raises $512K in Seed Funding to Further Expand Its Pathogen Testing Services

Ashburn, VA –, October 17, 2017 -- Aperiomics, a biotechnology company that saves lives by harnessing the power of deep next-generation sequencing to identify all known pathogens (bacteria, virus, fungi or parasite) in a single test, today announced the latest development in its growth. The company has closed a seed

By | October 18th, 2017|

Aperiomics Names Alvin Chen, PhD Chief Technology Officer

Ashburn, VA – August 8, 2017 -- Aperiomics, a biotechnology company that saves lives by harnessing the power of next-generation sequencing to identify any known pathogen (bacteria, virus, fungi or parasite) in a single test, today announced that Alvin (Yuan) Chen, PhD, has been named the company’s chief technology officer.

By | August 8th, 2017|

Biotechnology Company Aperiomics Launches New Website

Original article: http://citybizlist.com/article/433201/biotechnology-company-aperiomics-launches-new-website Ashburn, VA – August 1, 2017 --Aperiomics, a biotechnology company that saves lives by harnessing next-generation sequencing to identify any known pathogen (bacteria, virus, fungi or parasite) in a single test to pinpoint the causes of infectious disease, today launched its new website – http://www.aperiomics.com -- an information portal for

By | August 1st, 2017|

Aperiomics Names Robb Milne Director of Sales and Marketing

Ashburn, VA – August 1, 2017 -- Aperiomics, a biotechnology company that saves lives by harnessing the power of next-generation sequencing to identify any known pathogen (bacteria, virus, fungi or parasite) in a single test, today announced that Robb Milne has joined the company as Director of Sales and Marketing.

By | August 1st, 2017|

Aperiomics Launches New Website as Information Portal for Clinicians, Patients and Researchers

Ashburn, VA – July 31, 2017 -- Aperiomics, a biotechnology company that saves lives by harnessing next-generation sequencing to identify any known pathogen (bacteria, virus, fungi or parasite) in a single test to pinpoint the causes of infectious disease, today launched its new website – http://www.aperiomics.com -- an information portal

By | July 31st, 2017|

Aperiomics Mentioned in “Technically DC”

Original article: https://cbi.gwu.edu/aperiomics-mentioned-technically-dc July 26, 2017 Aperiomics, a spin-off company from a joint venture between Professor Keith Crandall, Director of the Computational Biology Institute, and The George Washington University, was mentioned in "Technically DC" on June 28th, 2017. Their participation in DC I-Corps, a National Science Foundation-funded regional program sponsored by

By | July 26th, 2017|

Aperiomics to present at Cavendish Global Health Impact Forum

Original article: https://www.vabio.org/news/news.asp?id=344198 Friday, May 5, 2017 Virginia Bio member, Aperiomics, a biotech company that has created a unique technology to revolutionize the diagnosis of infectious disease, has been selected to present at the Cavendish Global Health Impact Forum taking place May 7-9, 2017 in Washington, DC, co-hosted with the Virginia

By | May 5th, 2017|

Aperiomics Selected to Participate at Upcoming Cavendish Global Health Impact Forum

Sterling, VA, May 5, 2017 – Aperiomics, a biotech company that has created a unique technology to revolutionize the diagnosis of infectious disease, announced today it has been selected to present at the upcoming Cavendish Global Health Impact Forum taking place May 7-9, 2017 in Washington, DC, co-hosted with the

By | May 5th, 2017|

Aperiomics Brings Pathogen Testing to Integrative Healthcare Field

Original article: http://www.clpmag.com/2017/05/aperiomics-brings-pathogen-testing-integrative-healthcare-field/ Ashburn, VA – May 2, 2017 -- Aperiomics recently introduced its infectious disease diagnostic services to the integrative healthcare field at the annual Integrative Healthcare Symposium in New York City. With a single test of any biological sample, Aperiomics seeks to accurately identify all microbes present—including pathogens—whether bacteria,

By | May 2nd, 2017|

Webinar: Aperiomics Comprehensive Pathogen Testing

https://vimeo.com/200092539 Title: Use of Next-generation Sequencing for Pathogen Identification Technological advances in genomic sequencing are rapidly changing diagnostics. Learn how next-generation sequencing is being used to identify pathogens as never before. Dr. Crystal Icenhour, CEO of Aperiomics, will present technology that is able to identify over 1200 pathogens in

By | January 18th, 2017|

Nature.com Webcasts- Advances in Precision Medicine and Genomic Sequencing

Original article: http://www.nature.com/webcasts/event/advances-in-precision-medicine-and-genomic-sequencing/ Next-generation sequencing platforms are opening up new opportunities in precision medicine by dramatically reducing the cost and time to access large volumes of genomic data. This webcast will highlight innovative technologies being developed by companies in the field, and how they are laying the groundwork for novel therapeutics

By | November 29th, 2016|

Loudoun Tech Meetup with BioTech Startup Aperiomics

Original article: http://www.loudounsmallbiz.org/calendar/event-detail/2016/10/18/default-calendar/loudoun-tech-meetup-with-biotech-startup-aperiomics Join us for tech-minded conversation in a casual setting. Appetizers are on us- drinks are on you. This month we are excited to welcome Crystal Icenhour to lead a discussion on the emerging opportunities in the field of life sciences and bioscience in our region. This month Co-Founder

By | September 18th, 2016|

Business Rx: Her challenge is turning a service into a product

Original article: https://www.washingtonpost.com/news/on-small-business/wp/2016/09/14/business-rx-her-challenge-is-turning-a-service-into-a-product/?utm_term=.22e3dc06d630 By Special to The Washington Post September 14, 2016 This week, the leader of an Ashburn biotech start-up asks for advice on how to convert her diagnostic service into software that can be sold as a service.  –Dan Beyers The entrepreneur Scientist Crystal Icenhour earned her PhD as

By | September 14th, 2016|

Future is Now ~ Transforming Pathogen Diagnostics by @Aperiomcis’ Dr. Icenhour

Original article: http://www.mlo-online.com/the-transformation-of-pathogen-diagnostics-through-next-generation-sequencing Dr. Crystal R Icenhour Clinical laboratories have multiple methods for diagnosing infectious disease, but the fact remains that despite culture, microscopy, antibody-based testing, and molecular testing such as PCR, up to 75 percent of infections are not diagnosed in a timely manner, if at all.1,2

By | August 1st, 2016|

Medical Laboratory Observer Highlights Aperiomics’ Dr. Icenhour

MLO Aperiomics' Dr. Icenhour was recently profiled in Medical Laboratory Observer.  Dr. Icenhour highlights next generation sequencing and how it can be paired with advanced data analysis for accurate pathogen identification.  Aperiomics' unique data analytics are able to identify over 19,000 microbial species, which includes all sequenced pathogens. To read this

By | July 11th, 2016|

Aperiomics “Health & Life Sciences Innovator of the Year”

Innovation Awards Winner Aperiomics was selected from among five finalists as the Health & Life Sciences Innovator of the Year by the Northern Virginia Chamber of Commerce in their 2PndP Annual Greater Washington Innovation Awards. According to Northern Virginia Chamber President and CEO, Jim Corcoran, these award winners

By | July 8th, 2016|

There Isn’t a Pathogen Alive Capable of Eluding Diagnosis

Original article: http://www.innovatorsunder35.com/innovator/eduardo-castro Eduardo Castro 2016, Chile There isn´t a pathogen alive capable of eluding diagnosis, thanks to his software based on genetic sequencing Medicine Pinpointing the precise identity of the pathogen responsible for an illness can mark the difference between locating an effective cure and the patients finding themselves subjected

By | June 5th, 2016|

Aperiomics Launches Crowdfunding for Lyme Disease Project

Lyme Disease Aperiomics is offering even non-scientists an opportunity to improve human health. The company has launched a crowdfunding campaign to support an adaptation of their technology to develop a faster and more accurate test for Lyme Disease than any currently available. Existing tests for this disease have

By | April 22nd, 2016|

Aperiomics Expands Team Through National Science Foundation Award

Cory Strope Cory L. Strope, PhD, has joined Aperiomics as a new Bioinformatic Scientist in one of 50 positions nationwide that is funded through a special National Science Foundation initiative. The Small Business Postdoctoral Research Diversity Fellowship serves entrepreneurial companies who have received funding through the Phase II

By | March 15th, 2016|

Aperiomics, ResourcePath Partner for Pathogen Testing

Original article: https://www.genomeweb.com/informatics/aperiomics-resourcepath-partner-pathogen-testing?utm_source=TrendMD&utm_medium=TrendMD&utm_campaign=0   Dec 07, 2015   staff reporter NEW YORK (GenomeWeb) – Aperiomics and ResourcePath said today that they have entered into a strategic partnership to combine Aperiomics' data-analysis and bioinformatics technologies with ResourcePath's next-generation sequencing services for pathogen testing. The companies share space in Sterling, Virginia. ResourcePath, founded by

By | December 7th, 2015|

One Test Shows Every Bacteria, Virus and Parasite in Your Body – Biotech’s Future

https://www.youtube.com/watch?v=Kc-3yLKgVBo   National Science Foundation Published on Nov 8, 2015 Aperiomics, a small business funded by the National Science Foundation Small Business Innovation Research program, is developing a test that can identify a wide range of pathogens in one biological sample. Crystal Icenhour, CEO of Aperiomics, explains the technology

By | November 8th, 2015|

Aperiomics Receives National Science Foundation Award

NSF SBIR Phase II Grant Brings Company’s NSF Awards Total to Nearly $1 Million  Aperiomics has won its second award in a year through the National Science Foundation’s Small Business Innovation Research (SBIR) program. This new SBIR Phase II grant of nearly $737,000 follows earlier feasibility funding from

By | September 16th, 2015|

APHL 2015 POSTER: Emerging virus discovery through meta-transcriptomics

Aperiomics Association for Public Health Labs 2015 Annual Meeting Poster Presentation Emerging virus discovery through meta-transcriptomics: a novel virus impacting Rainbow Trout (Oncorhynchus mykiss) farming in Chile ABSTRACT Viral pathogen discovery is critically important to clinical microbiology, infectious diseases, and public health. During 2012-13 there was an outbreak

By | May 19th, 2015|

Aperiomics Receives Follow-on NSF Grant to Develop Pathogen ID Platform

Original article: https://www.genomeweb.com/business-news/aperiomics-receives-follow-nsf-grant-develop-pathogen-id-platform?utm_source=TrendMD&utm_medium=TrendMD&utm_campaign=0 Jan 15, 2015  staff reporter NEW YORK (GenomeWeb) – Aperiomics has received a Phase 1B grant from the National Science Foundation's Small Business Innovation Research program to bring the company's current award total from the program to just under $180,000. According to the grant abstract, Aperiomics intends to "develop,

By | January 15th, 2015|

Aperiomics Receives Second National Science Foundation SBIR Award

National Science Foundation Aperiomics has been awarded a Phase IB grant through the National Science Foundation’s Small Business Innovation Research (SBIR) program, bringing their current award total to nearly $180,000 from this program. The project, under the direction of Aperiomics Chief Science Officer Eduardo Castro-Nallar, PhD, is titled

By | January 12th, 2015|

Aperiomics CEO Icenhour to Present at Biotech Showcase 2015

Biotech Showcase Like swallows to Capistrano, investors interested in new opportunities in healthcare and life science sectors will be flocking to San Francisco in mid-January to discover fresh options at a cluster of related conferences where companies will present their investment needs during the 2015 JP Morgan Healthcare

By | January 8th, 2015|

Harnessing the Power of Next-Generation Sequencing

Dr. Crystal Icenhour: Leader of The Science Advisory Board’s Next-Generation Sequencing Team Dr. Icenhour earned her Ph.D.  in Pathobiology and Molecular Medicine from the University of Cincinnati Medical School of Graduate Studies in 2002. She went on to conduct postdoctoral research in the Thoracic Diseases Research Unit at the Mayo Clinic College

By | November 10th, 2014|

Aperiomics Launches First Commercial Services

Aperiomics, founded in October 2013, is bringing ground-breaking solutions to market to address age-old life and death disease challenges. The company will introduce its breakthrough Absolute-NGS™ Pathogen Detection Platform to the Association for Molecular Pathology at the upcoming AMP 2014 Annual Meeting (Booth #1253) to be held November 12-15 near

By | November 3rd, 2014|